Cargando…
Platinum-Based Nanovectors Engineered with Immuno-Modulating Adjuvant for Inhibiting Tumor growth and Promoting Immunity
Although there is ample evidence that the chemotherapeutic drugs trigger an immune response, the efficient tumor rejection or regression is not guaranteed probably due to the massive immunosuppression within the tumor microenvironment. Thus, a rational delivery platform that overcomes immunosuppress...
Autores principales: | Liu, Lisha, Chen, Qinjun, Ruan, Chunhui, Chen, Xinli, Zhang, Yu, He, Xi, Zhang, Yujie, Lu, Yifei, Guo, Qin, Sun, Tao, Wang, Hao, Jiang, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996371/ https://www.ncbi.nlm.nih.gov/pubmed/29896297 http://dx.doi.org/10.7150/thno.24110 |
Ejemplares similares
-
Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma
por: Ruan, Chunhui, et al.
Publicado: (2018) -
Microenvironment Remodeling Micelles for Alzheimer's Disease Therapy by Early Modulation of Activated Microglia
por: Lu, Yifei, et al.
Publicado: (2018) -
Sequentially Triggered Nanoparticles with Tumor Penetration and Intelligent Drug Release for Pancreatic Cancer Therapy
por: He, Xi, et al.
Publicado: (2018) -
Alzheimer's Disease: Microenvironment Remodeling Micelles for Alzheimer's Disease Therapy by Early Modulation of Activated Microglia (Adv. Sci. 4/2019)
por: Lu, Yifei, et al.
Publicado: (2019) -
Enhanced bioreduction-responsive diselenide-based dimeric prodrug nanoparticles for triple negative breast cancer therapy
por: He, Xi, et al.
Publicado: (2018)